In psoriasis, immune-metabolic interactions may orchestrate IL-17-induced pathogenicity, which can induce skin plaques as well as systemic inflammatory responses and psoriasis-related comorbidities (Krueger and Brunner, 2018). The gene discussed is IL17A; the disease is psoriasis.